Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Beijing Airdoc Technology Co. Ltd. Class H ( (HK:2251) ) has shared an update.
Beijing Airdoc Technology Co., Ltd. has issued a profit warning, anticipating a significant increase in losses for the year ended December 31, 2024, primarily due to regulatory changes affecting its laser-based myopia treatment products. The new regulations have led to reduced revenue, goodwill impairment, and increased R&D expenses as the company adapts its product portfolio. Despite these challenges, the company has received regulatory approval for its LED-based myopia treatment product, which is expected to drive future revenue growth.
More about Beijing Airdoc Technology Co. Ltd. Class H
Beijing Airdoc Technology Co., Ltd. operates in the healthcare technology industry, focusing on AI-driven myopia treatment solutions. The company offers laser-based and LED-based myopia treatment products, with a market focus on addressing the rising prevalence of myopia, particularly among young people.
YTD Price Performance: 21.59%
Average Trading Volume: 178,770
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.98B
For an in-depth examination of 2251 stock, go to TipRanks’ Stock Analysis page.